3D bioprinting has the capability to create 3D cellular constructs with the desired shape using a layer-by-layer approach.Inkjet 3D bioprinting,as a key component of 3D bioprinting,relies on the deposition of cell-lad...3D bioprinting has the capability to create 3D cellular constructs with the desired shape using a layer-by-layer approach.Inkjet 3D bioprinting,as a key component of 3D bioprinting,relies on the deposition of cell-laden droplets to create native-like tissues/organs which are envisioned to be transplantable into human body for replacing damaged ones.Benefiting from its superiorities such as high printing resolution and deposition accuracy,inkjet 3D bioprinting has been widely applied to various areas,including,but not limited to,tissue engineering and drug screening in pharmaceutics.Even though inkjet 3D bioprinting has proved its feasibility and versatility in various fields,the current applications of inkjet 3D bioprinting are still limited by the printing technique and material selection.This review,which specifically focuses on inkjet 3D bioprinting,firstly summarizes the techniques,materials,and applications of inkjet 3D bioprinting in tissue engineering and drug screening,subsequently discusses the major challenges that inkjet 3D bioprinting is facing,and lastly summarizes potential solutions to those challenges.展开更多
In situ bioprinting is promising for developing scaffolds directly on defect models in operating rooms,which provides a new strategy for in situ tissue regeneration.However,due to the limitation of existing in situ bi...In situ bioprinting is promising for developing scaffolds directly on defect models in operating rooms,which provides a new strategy for in situ tissue regeneration.However,due to the limitation of existing in situ biofabrication technologies including printing depth and suitable bioinks,bioprinting scaffolds in deep dermal or extremity injuries remains a grand challenge.Here,we present an in vivo scaffold fabrication approach by minimally invasive bioprinting electroactive hydrogel scaffolds to promote in situ tissue regeneration.The minimally invasive bioprinting system consists of a ferromagnetic soft catheter robot for extrusion,a digital laparoscope for in situ monitoring,and a Veress needle for establishing a pneumoperitoneum.After 3D reconstruction of the defects with computed tomography,electroactive hydrogel scaffolds are printed within partial liver resection of live rats,and in situ tissue regeneration is achieved by promoting the proliferation,migration,and differentiation of cells and maintaining liver function in vivo.展开更多
基金supported by the Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study(No.SN-ZJU-SIAS-004)the National Natural Science Foundation of China(No.52075482)。
文摘3D bioprinting has the capability to create 3D cellular constructs with the desired shape using a layer-by-layer approach.Inkjet 3D bioprinting,as a key component of 3D bioprinting,relies on the deposition of cell-laden droplets to create native-like tissues/organs which are envisioned to be transplantable into human body for replacing damaged ones.Benefiting from its superiorities such as high printing resolution and deposition accuracy,inkjet 3D bioprinting has been widely applied to various areas,including,but not limited to,tissue engineering and drug screening in pharmaceutics.Even though inkjet 3D bioprinting has proved its feasibility and versatility in various fields,the current applications of inkjet 3D bioprinting are still limited by the printing technique and material selection.This review,which specifically focuses on inkjet 3D bioprinting,firstly summarizes the techniques,materials,and applications of inkjet 3D bioprinting in tissue engineering and drug screening,subsequently discusses the major challenges that inkjet 3D bioprinting is facing,and lastly summarizes potential solutions to those challenges.
基金supported by the National Natural Science Foundation of China(52173280,51820105008,82173315,82072068,81773104,81873931,and 81974382)the Technical Innovation Major Foundation Program of Hubei Province(2018ACA136)+1 种基金the Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College,HUSTthe Academic Doctor-Supporting Program of Tongji Medical College,HUST.
文摘In situ bioprinting is promising for developing scaffolds directly on defect models in operating rooms,which provides a new strategy for in situ tissue regeneration.However,due to the limitation of existing in situ biofabrication technologies including printing depth and suitable bioinks,bioprinting scaffolds in deep dermal or extremity injuries remains a grand challenge.Here,we present an in vivo scaffold fabrication approach by minimally invasive bioprinting electroactive hydrogel scaffolds to promote in situ tissue regeneration.The minimally invasive bioprinting system consists of a ferromagnetic soft catheter robot for extrusion,a digital laparoscope for in situ monitoring,and a Veress needle for establishing a pneumoperitoneum.After 3D reconstruction of the defects with computed tomography,electroactive hydrogel scaffolds are printed within partial liver resection of live rats,and in situ tissue regeneration is achieved by promoting the proliferation,migration,and differentiation of cells and maintaining liver function in vivo.
